Sign up to save your podcasts
Or
Share 323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates
Mizuho analyst Jared Holz joins us to discuss what the Federal Reserve's long-awaited decision to lower interest rates means for biotech stocks and startups. Elaine, Adam, and Allison also discuss the latest news in life sciences, including the use of cannabinoid receptor drugs in weight loss and the Lasker Awards, a.k.a. "America's Nobel."
View all episodes
By STAT
4.5
304304 ratings
Mizuho analyst Jared Holz joins us to discuss what the Federal Reserve's long-awaited decision to lower interest rates means for biotech stocks and startups. Elaine, Adam, and Allison also discuss the latest news in life sciences, including the use of cannabinoid receptor drugs in weight loss and the Lasker Awards, a.k.a. "America's Nobel."
More shows like The Readout Loud
View all
Planet Money
30,845 Listeners
a16z Podcast
1,040 Listeners
Odd Lots
1,789 Listeners
KFF Health News' 'What the Health?'
478 Listeners
The Long Run with Luke Timmerman
122 Listeners
Talks at GS
84 Listeners
The Journal.
5,942 Listeners
Tradeoffs
391 Listeners
Biotech 2050 Podcast
59 Listeners
BioCentury This Week
29 Listeners
Hard Fork
5,462 Listeners
Raising Health
147 Listeners
Biotech Hangout
18 Listeners
Ground Truths
51 Listeners
Money Stuff: The Podcast
371 Listeners